Details
Category: Volume 08 Issue 03 March 2020
Hits: 1525

Title: Spectrum of Endocrine Disorders in Patients Attending Endocrine OPD in a Tertiary Care Hospital in Bangladesh

Authors: Dr Indrajit Prasad, Dr Joysree Saha, Dr Sujit Kumar Sarker, Prof. Dr Md Hafizur Rahman, Dr Ajit Kumar Paul, Dr Debesh Chandra Talukder

 DOI: https://dx.doi.org/10.18535/jmscr/v8i3.05

Abstract

   

Endocrine disorders are primarily diseases of the pancreas thyroid, parathyroid, pituitary, gonad, and adrenal glands, thusly, it constitutes a major health problem in all the societies. At present, an improved insight into the diagnosis, pathophysiology and molecular bases it is possible to diagnose the disorders earlier in their development. As a result of the treatment of the deficiency states for most hormones is successful. Furthermore, with recognition, many of these disorders are either the consequence of single-gene mutations or have a major genetic component. Therapies for the syndromes of hormone overproduction are less successful and frequently result in destruction of the endocrine organ involved and the treatment of hormone resistance states is similarly unsatisfactory. These disorders are candidates for the development of super agonists/antagonists and gene therapies. The overall objective of this study is to find out the frequency of endocrine disorders in patients attending endocrine OPD in Lab Aid Specialized Hospital, a tertiary care hospital in Bangladesh. Overweight and obesity are commonly subject to endocrine disorder. Thyroid disorders were significantly higher in female. Patients with TD had strong association with family history of TD. In this study 438 patients were enrolled endocrine department OPD. The study found that diabetes was the commonest introducing endocrine issue, trailed by thyroid organ issue and adrenal issue. Universally, diabetes and thyroid issue speak to the two commonest of endocrinological clutters.

References

  1. DeLange F, Ermans Not Available. Iodine deficiency In: Braverman LE, Utiger RD, eds. Werner and Ingbar's The Thyroid. 6th ed. Philadelphia, Pa: JB Lippincott Co; 1991:368-389.
  2. Grollman A. Clinical Endocrinology and Its Physiologic Basis. Philadelphia, Pa: JB Lippincott Co; 1962:20.
  3. Sawin CT, Geller A, Hershman JM, Castelli CO, Bacharach P. The aging thyroid: the use of thyroid hormones in older persons. 1989; 261:2653-2655.Google Scholar
  4. Griffin JE, McPhaul MJ, Russell DW, Wilson JD. The androgen resistance syndromes: steroid 5-reductase 2 deficiency, testicular feminization, and related disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease 7th ed. New York, NY: McGraw-Hill; in press.
  5. Refetoff S, Weiss RE, Usala SJ. The syndromes of resistance to thyroid hormone Endocr Rev.1993; 14:348-399.Google Scholar
  6. Whitfield M. D., Gillett M., Holmes M., Ogden E. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period—a pilot study. Public Health. 2006;120(12):1140–1148. doi: 10.1016/j.puhe.2006.10.012. [PubMed] [CrossRef] [Google Scholar]
  7. Sathish R., Mohan V. Diabetes and thyroid diseases—a review. International Journal of Diabetes in Developing Countries. 2010;23(4):120–123. [Google Scholar]
  8. Papazafiropoulou A., Sotiropoulos A., Kokolaki A., Kardara M., Stamataki P., Pappasa S. Prevalence of thyroid dysfunction amongst Greek type 2 diabetes mellitus patients attending an outpatient clinic. Journal of Clinical Medical Research. 2010;2(2):75–78. doi: 10.4021/jocmr2010.03.281w. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  9. Brenta G. Diabetes and thyroid disorders. British Journal of Diabetes and Vascular Disease. 2010;10(4):172–177. doi:10.1177/1474651410371321. [CrossRef] [Google Scholar]
  1. Shaw J. E., Sicree R. A., Zimmet P. Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice. 2010;87(1):4–14. doi: 10.1016/j.diabres.2009.10.007. [PubMed] [CrossRef] [Google Scholar]
  2. Guariguata L., Whiting D. R., Hambleton I., Beagley J., Linnenkamp U., Shaw J. E. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Research and Clinical Practice. 2010; 103(2):137–149. doi: 10.1016/j.diabres.2013.11.002. [PubMed] [CrossRef] [Google Scholar]
  3. Hall V., Thomsen R. W., Henriksen O., Lohse N. Diabetes in sub-Saharan Africa 1999–2011: epidemiology and public health implications—a systemic review. BMC Public Health. 2010;11(1, article 564) doi: 10.1001/jamapediatrics.2016.3917. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 1
  4. Mbanya J. C., Motala A. A., Sobngwi E., Assah F. K., Enoru S. T. Diabetes in sub-Saharan Africa. The Lancet. 2010;375 (9733):2254–2266. doi: 10.1016/S0140-6736(10)60550-8. [PubMed] [CrossRef] [Google Scholar]
  5. Wild S, Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care. 2010;27(5):1047–1053. doi: 10.2337/diacare.27.5.1047. [PubMed] [CrossRef] [Google Scholar]
  6. Agyei-Mensah S., de-Graft Aikins A. Epidemiological transition and the double burden of disease in Accra, Ghana. Journal of Urban Health. 2010;87 (1):879–897. doi: 10.1007/s11524-010-9492-y. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  7. de-Graft Aikins A., Unwin N., Agyemang C., Allotey P., Campbell C., Arhinful D. Tackling Africa’s chronic disease burden: from the local to the global. Globalization and Health. 2010;6(1, article 5) doi: 10.1093/bmb/ldr03036. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  8. Ocansey R., Aryeetey R., Sofo S., Delali M. B., Pambo P., Nyawornota V. K. Results from Ghana’s 2014 report card on physical activity for children and youth. Journal of Physical Activity & Health. 2014;11(supplement 1):S58–S62. doi: 10.1123/jpah.2014-0171. [PubMed] [CrossRef] [Google Scholar]
  9. Abubakari A. R., Lauder W., Jones M. C., Kirk A., Agyemang C., Bhopal R. S. Prevalence and time trends in diabetes and physical inactivity among adult West African populations: the epidemic has arrived. Public Health. 2009;123(9):602–614. doi: 10.1016/j.puhe.2009.07.009. [PubMed] [CrossRef] [Google Scholar]
  10. Commodore-Mensah Y., Samuel L. J., Dennison-Hemmelfarb C. R., Agyemang C. Hypertension and overweight/obesity in Ghanaians and Nigerians living in West Africa and industrialized countries: a systematic review. Journal of Hypertension. 2014;32(3):464–472. doi: 10.1161/JAHA.116.004059. [PubMed] [CrossRef] [Google Scholar]
  11. Dake F. A., Tawiah E. O., Badasu D. M. Sociodemographic correlates of obesity among Ghanaian women. Public Health Nutrition. 2011;11(7):1285–1291. doi: 10.1017/S1368980010002879. [PubMed] [CrossRef] [Google Scholar]
  12. Ghana Country Profile.   http://www.who.int/nmh/countries/en/
  13. Micah F. B., Nkum B. C. Lipid disorders in hospital attendants in Kumasi, Ghana. Ghana Medical Journal. 2012;46(1):14–21. [PMC free article] [PubMed] [Google Scholar]
  14. Hill A. G., Darko R., Seffah J., Adanu R. M., Anarfi J. K., Duda R. B. Health of urban Ghanaian women as identified by the Women’s Health Study of Accra. International Journal of Gynaecology and Obstetrics. 2009; 99(2):150–156. doi: 10.1016/j.ijgo.2007.05.024. [PubMed] [CrossRef] [Google Scholar]
  15. Okosieme O. E. Impact of iodination on thyroid pathology in Africa. Journal of the Royal Society of Medicine. 2000; 99 (8):396–401. doi: 10.1258/jrsm.99.8.396. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  16. Pearce E. N., Andersson M., Zimmermann M. B. Global iodine nutrition: where do we stand in 2013? Thyroid. 2013;23(5):523–528. doi: 10.1089/thy.2013.0128. [PubMed] [CrossRef] [Google Scholar]
  17. Vanderpump M. P. The epidemiology of thyroid disease. British Medical Bulletin. 2010;99:39–51. doi: 10.1093/bmb/ldr030. [PubMed] [CrossRef] [Google Scholar]
  18. Ogbera A. O., Kuku S. F. Epidemiology of thyroid diseases in Africa. Indian Journal of Endocrinology and Metabolism. 2011;15(6) supplement 2:S82–S88. doi: 10.1186/s13104-015-1423-2. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  19. http://www.who.int/vmnis/database/iodine/iodine_data_status summary/en/index.html.
  20. Okosieme O. E. Impact of iodination on thyroid pathology in Africa. Journal of the Royal Society of Medicine. 2006; 99(8):396–401. doi: 10.1258/jrsm.99.8.396. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  21. http://www.unicef.org/wsc/goals.htm.
  22. Vanderpump M. P., Lazarus J. H., Smyth P. P., et al. Iodine status of UK schoolgirls: a cross-sectional survey. Lancet. 2011;377(9782):2007–2012. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)60693-4/fulltext. [PubMed] [Google Scholar]
  23. Young W. F. The incidentally discovered adrenal mass. The New England Journal of Medicine. 2007;356(6):601–610. doi: 10.1056/NEJMcp065470. [PubMed] [CrossRef] [Google Scholar]
  24. Kibirige D. Endocrine dysfunction among adults with tuberculosis: an African experience. Indian Journal of Endocrinology and Metabolism. 2014; 18(3):288–294. doi: 10.4103/2230-8210.131136. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  25. Odeniyi I. A., Fasanmade O. A., Ajala M. O., Ohwovoriole A. E. Adrenocortical function in Nigerian patients with pulmonary tuberculosis (PTB) African Journal of Medicine and Medical Sciences. 2011;40(1):33–38. [PubMed] [Google Scholar]

Corresponding Author

Dr Indrajit Prasad

Associate Professor, Department of Endocrinology, Dhaka Medical College, Dhaka